PMC:7195088 / 26792-26992
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T132","span":{"begin":139,"end":147},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"p 14 days).\n• Comparison of tocilizumab plus hydroxychloroquine plus azithromycin vs. tocilizumab plus hydroxychloroquine in patients with COVID-19. Open-label RCT (NCT04332094, not yet recruiting). P"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T140","span":{"begin":154,"end":159},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"p 14 days).\n• Comparison of tocilizumab plus hydroxychloroquine plus azithromycin vs. tocilizumab plus hydroxychloroquine in patients with COVID-19. Open-label RCT (NCT04332094, not yet recruiting). P"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T358","span":{"begin":28,"end":39},"obj":"Chemical"},{"id":"T359","span":{"begin":45,"end":63},"obj":"Chemical"},{"id":"T360","span":{"begin":69,"end":81},"obj":"Chemical"},{"id":"T361","span":{"begin":86,"end":97},"obj":"Chemical"},{"id":"T362","span":{"begin":103,"end":121},"obj":"Chemical"},{"id":"T363","span":{"begin":154,"end":159},"obj":"Chemical"}],"attributes":[{"id":"A358","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A359","pred":"chebi_id","subj":"T359","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A360","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A361","pred":"chebi_id","subj":"T361","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A362","pred":"chebi_id","subj":"T362","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A363","pred":"chebi_id","subj":"T363","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"p 14 days).\n• Comparison of tocilizumab plus hydroxychloroquine plus azithromycin vs. tocilizumab plus hydroxychloroquine in patients with COVID-19. Open-label RCT (NCT04332094, not yet recruiting). P"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T199","span":{"begin":12,"end":148},"obj":"Sentence"},{"id":"T200","span":{"begin":149,"end":198},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"p 14 days).\n• Comparison of tocilizumab plus hydroxychloroquine plus azithromycin vs. tocilizumab plus hydroxychloroquine in patients with COVID-19. Open-label RCT (NCT04332094, not yet recruiting). P"}